-
Forward Look
Little Consensus on Ovarian Cancer MonitoringTests and scans may be overused.
by Kate Yandell
-
Forward Look
No Link Found Between IVF and Breast Cancer RiskStudy findings will reassure many families.
by Cameron Walker
-
Forward Look
All About OverdiagnosisQ&A with epidemiologist Pam Marcus on why cancer screening can have risks.
by Sue Rochman
-
Forward Look
Thyroid Tumor Gets New NamePanel reclassifies a type of thyroid tumor, says it's not cancer.
by Yasmine Iqbal
-
-
Forward Look
Many Cancers in HIV-Positive Patients Go UntreatedStudy suggests need to educate patients with HIV and their doctors.
by Kate Yandell
-
Forward Look
Do You Know BRCA?Learn more about educational efforts to increase understanding of the 'breast cancer' gene.
by Sue Rochman
-
A Rural ChallengeNearly 20 percent of Americans live in rural areas, but only 3 percent of oncologists practice in them. Health care providers are establishing rural outposts and using advanced technology to diagnose and treat patients living in the country.
by Charlotte Huff
-
Cancer Comes OutMembers of LGBT community are at greater risk for some types of cancer. And those with cancer face challenges in getting the care and support they need.
by Cameron Walker
-
Healthy Habits
Fruitful ChoicesEating fruits in teen years associated with lower breast cancer risk later.
by Lindsey Konkel
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
